A carregar...
Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies
Eslicarbazepine acetate (ESL) is a once-daily antiepileptic drug that is approved as adjunctive therapy in adults with focal-onset seizures. Following oral administration, ESL is rapidly metabolized to its active metabolite, eslicarbazepine, which acts primarily by enhancing slow inactivation of vol...
Na minha lista:
| Publicado no: | J Neurol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Berlin Heidelberg
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5336540/ https://ncbi.nlm.nih.gov/pubmed/28101651 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-016-8338-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|